COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.

Erol DemirMurathan UyarErgün ParmaksizAyse SinangilBerna YelkenAhmet Burak DirimOzgur MerhametsizSerap Yadigar Zuhal Atan UcarAli Riza UcarMehmet Emin Demir Meral Meşe Emin Baris AkinNurana GarayevaSeda SafakOzgur Akin OtoHalil Yazici Aydın Turkmen

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2020)

COVID-19 has been seen to more commonly cause moderate or severe pneumonia in kidney transplant recipients. Immunosuppression should be carefully reduced in these patients. Induction therapy with lymphocyte-depleting agents should be carefully avoided in kidney transplant recipients during the pandemic period.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
early onset
intensive care unit
patient reported outcomes
bone marrow
cell therapy
smoking cessation
community acquired pneumonia